Primaquine to reduce transmission of Plasmodium falciparum malaria in Mali: a single-blind, dose-ranging, adaptive randomised phase 2 trial

The Lancet Infectious Diseases

Volumn 16, Issue 6, 2016, Pages 674-684

  Dicko, Alassane ^a   Brown, Joelle M ^b   Diawara, Halimatou ^a   Baber, Ibrahima ^a   Mahamar, Almahamoudou ^a   Soumare, Harouna M ^a   Sanogo, Koualy ^a   Koita, Fanta ^a   Keita, Sekouba ^a   Traore, Sekou F ^a   Chen, Ingrid ^c   Poirot, Eugenie ^b,c   Hwang, Jimee ^c,d,e   McCulloch, Charles ^b   Lanke, Kjerstin ^f   Pett, Helmi ^f,h   Niemi, Mikko ^h   Nosten, François ^i,j   Bousema, Teun ^f,g   Gosling, Roly ^b,c  

^a UNIVERSITY OF BAMAKO   (Mali)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e President's Malaria Initiative   (United States)

^f RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^g LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^h HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

ⁱ UNIVERSITY OF OXFORD   (United Kingdom)

^j SHOKLO MALARIA RESEARCH UNIT   (Thailand)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROARTEMISININ PLUS PIPERAQUINE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HEMOGLOBIN; PRIMAQUINE; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; DIHYDROARTEMISININ; PIPERAQUINE; QUINOLINE DERIVATIVE;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ARTICLE; BACKACHE; BRONCHITIS; BURNING SENSATION; CHILD; COLORIMETRY; CONTROLLED STUDY; COUGHING; DIARRHEA; DISEASE TRANSMISSION; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; DYSPNEA; DYSURIA; FATIGUE; FEVER; FOLLOW UP; GAMETOCYTE; HEADACHE; HEMOGLOBIN DETERMINATION; HEMOLYSIS; HUMAN; INFECTION PREVENTION; LOSS OF APPETITE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALARIA CONTROL; MALARIA FALCIPARUM; MALE; MALI; MYALGIA; NAUSEA; OSTEOARTHRITIS; OUTCOME ASSESSMENT; PARASITE PREVALENCE; PHASE 2 CLINICAL TRIAL; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; RHINOBRONCHITIS; RHINORRHEA; SINGLE DRUG DOSE; TABLET; TREATMENT OUTCOME; VOMITING; ANIMAL; ANOPHELES GAMBIAE; CLINICAL TRIAL; COMBINATION DRUG THERAPY; DRUG ADMINISTRATION; MALARIA, FALCIPARUM; PARASITOLOGY; SINGLE BLIND PROCEDURE; TRANSMISSION;

ANIMALS; ANOPHELES GAMBIAE; ANTIMALARIALS; ARTEMISININS; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; HUMANS; MALARIA, FALCIPARUM; MALI; PRIMAQUINE; QUINOLINES; SINGLE-BLIND METHOD;

EID: 84958581636     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(15)00479-X     Document Type: Article

References (30)

1. 1 WHO. World Malaria Report, 2014, World Health Organization, Geneva.
2. 2 Noor, AM, Kinyoki, DK, Mundia, CW, et al. The changing risk of Plasmodium falciparum malaria infection in Africa: 2000–10: a spatial and temporal analysis of transmission intensity. Lancet 383 (2014), 1739–1747.
3. 3 Griffin, JT, Hollingsworth, TD, Okell, LC, et al. Reducing Plasmodium falciparum malaria transmission in Africa: a model-based evaluation of intervention strategies. PLoS Med, 7, 2010, e1000324.
4. 4 Cotter, C, Sturrock, HJ, Hsiang, MS, et al. The changing epidemiology of malaria elimination: new strategies for new challenges. Lancet 382 (2013), 900–911.
5. 5 WHO. Evidence review group on the safety and efficacy of gametocytocidal doses of primaquine for Plasmodium falciparum malaria, 2012, World Health Organization, Geneva.
6. 6 Ruwende, C, Khoo, SC, Snow, RW, et al. Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria. Nature 376 (1995), 246–249.
7. 7 White, NJ, Qiao, LG, Qi, G, Luzzatto, L, Rationale for recommending a lower dose of primaquine as a Plasmodium falciparum gametocytocide in populations where G6PD deficiency is common. Malar J, 11, 2012, 418.
8. 8 Eziefula, AC BT, Yeung, S, Kamya, M, et al. Single dose primaquine for clearance of Plasmodium falciparum gametocytes in children with uncomplicated malaria in Uganda: a randomised, controlled, double-blind, dose-ranging trial. Lancet Infect Dis 14 (2014), 130–139.
9. 9 White, NJ, Ashley, EA, Recht, J, et al. Assessment of therapeutic responses to gametocytocidal drugs in Plasmodium falciparum malaria. Malar J, 13, 2014, 483.
10. 10 Chen, I, Poirot, E, Newman, M, et al. An assessment of the supply, programmatic use, and regulatory issues of single low-dose primaquine as a Plasmodium falciparum gametocytocide for sub-Saharan Africa. Malar J, 14, 2015, 204.
11. 11 Dicko, A, Diallo, AI, Tembine, I, et al. Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in mali: a randomised, double-blind, placebo-controlled trial. PLoS Med, 8, 2011, e1000407.
12. 12 Ouedraogo, AL, Guelbeogo, WM, Cohuet, A, et al. A protocol for membrane feeding assays to determine the infectiousness of P. falciparum naturally infected individuals to Anopheles gambiae. Malaria World J, 4, 2013, 16.
13. 13 Wampfler, R, Mwingira, F, Javati, S, et al. Strategies for detection of Plasmodium species gametocytes. PLoS One, 8, 2013, e76316.
14. 14 Schneider, P, Wolters, L, Schoone, G, et al. Real-time nucleic acid sequence-based amplification is more convenient than real-time pcr for quantification of Plasmodium falciparum. J Clin Microbiol 43 (2005), 402–405.
15. 15 Zanger, UM, Raimundo, S, Eichelbaum, M, Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry. Naunyn Schmiedebergs Arch Pharmacol 369 (2004), 23–37.
16. 16 Gaedigk, A, Simon, SD, Pearce, RE, Bradford, LD, Kennedy, MJ, Leeder, JS, The CYP2D6 activity score: translating genotype information into a qualitative measure of phenotype. Clin Pharmacol Ther 83 (2008), 234–242.
17. 17 Shekalaghe, S, Drakeley, C, Gosling, R, et al. Primaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate. PLoS One, 10, 2007, e1023.
18. 18 Bennett, JW, Pybus, BS, Anjali, Y, Tosh, D, Sousa, JC, Primaquine failure and cytochrome P-450 2D6 in Plasmodium vivax malaria. N Engl J Med 269 (2013), 1381–1382.
19. 19 Bousema, T, Dinglasan, RR, Morlais, I, et al. Mosquito feeding assays to determine the infectiousness of naturally infected Plasmodium falciparum gametocyte carriers. PLoS One, 7, 2012, e42821.
20. 20 Sawa, P, Shekalaghe, SA, Drakeley, CJ, et al. Malaria transmission after artemether-lumefantrine and dihydroartemisinin-piperaquine: a randomized trial. J Infect Dis 207 (2013), 1637–1645.
21. 21 White, NJ, Primaquine to prevent transmission of falciparum malaria. Lancet Infect Dis 13 (2013), 175–181.
22. 22 Sutanto, I, Suprijanto, S, Kosasih, A, et al. The effect of primaquine on gametocyte development and clearance in the treatment of uncomplicated falciparum malaria with dihydroartemisinin-piperaquine in South sumatra, Western indonesia: an open-label, randomized, controlled trial. Clin Infect Dis 56 (2013), 685–693.
23. 23 Smithuis, F, Kyaw, MK, Phe, O, et al. Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial. Lancet Infect Dis 10 (2010), 673–681.
24. 24 Schneider, P, Reece, SE, van Schaijk, BC, et al. Quantification of female and male Plasmodium falciparum gametocytes by reverse transcriptase quantitative PCR. Mol Biochem Parasitol 199 (2015), 29–33.
25. 25 Delves, MJ, Ruecker, A, Straschil, U, et al. Male and female Plasmodium falciparum mature gametocytes show different responses to antimalarial drugs. Antimicrob Agents Chemother 57 (2013), 3268–3274.
26. 26 Bousema, T, Okell, L, Felger, I, Drakeley, C, Asymptomatic malaria infections: detectability, transmissibility and public health relevance. Nat Rev Microbiol 12 (2014), 833–840.
27. 27 Ouedraogo, AL, Gonçalves, BP, Gneme, A, et al. Dynamics of the human infectious reservoir for malaria determined by mosquito feeding assays and ultrasensitive malaria diagnosis in Burkina Faso. J Infect Dis, 2015, 10.1093/infdis/jiv370 published online July 3.
28. 28 Eziefula, AC, Pett, H, Grignard, L, et al. Glucose-6-phosphate dehydrogenase status and risk of hemolysis in Plasmodium falciparum-infected African children receiving single-dose primaquine. Antimicrob Agents Chemother 58 (2014), 4971–4973.
29. 29 Chen, IT, Gosling, RD, Targeting Plasmodium falciparum with primaquine: same efficacy, improved safety with a lower dose?. Expert Rev Clin Pharm 7 (2014), 681–686.
30. 30 Deen, JL, von Seidlein, L, Pinder, M, Walraven, GE, Greenwood, BM, The safety of the combination artesunate and pyrimethamine-sulfadoxine given during pregnancy. Trans R Soc Trop Med Hyg 95 (2001), 424–428.